Dr Alan Goddard

Senior Lecturer, School of Biosciences Aston University

  • Birmingham

Dr Goddard's research interests focus around membrane proteins and the lipid membranes in which they reside.

Contact

Aston University

View more experts managed by Aston University

Spotlight

3 min

New podcast: Aston University research institute team discuss membrane separations and chocolate boxes

Aston Institute of Membrane Excellence’s Dr Matt Derry was joined by Dr Alan Goddard and France-based research partner Dr Mona Semsarilar They discussed the BIOMEM project, which received £3m from the European Innovation Council (EIC) Pathfinder programme BIOMEM will develop a bioinspired membrane to selectively extract compounds from water (like finding a favourite chocolate in a box) In the latest Aston Institute for Membrane Excellence (AIME) podcast, three researchers discuss the international BIOmimetic selective extraction MEMbranes (BIOMEM) project and how it will feed into AIME’s work. BIOMEM will develop a bioinspired membrane technology to selectively extract compounds from water, using 50-75% less energy than current state-of-the-art nanofiltration technologies. The membranes will work at low pressures and at low concentration of the target molecule. Podcast host Dr Matt Derry was joined by fellow AIME researcher Dr Alan Goddard and Dr Mona Semsarilar from the French National Centre for Scientific Research (Centre national de la recherche scientifique (CNRS)). The BIOMEM project, which involves collaborators from across Europe, is being led by Dr Torsten Bak from Danish company Aquaporin, with Dr Goddard the research lead at Aston University. Dr Goddard explained: “You might want to work on a biotechnology process where you've made a high value chemical that you want to extract from a complex mix, and at the moment you might have to concentrate your solution up, and you might have to do six or seven filtration steps. We want a filter that does it in a single step using a biological transporter. “And if you can do that in a single step in a platform technology, you'll make all these brilliant biotech processes more commercialisable, reduce your reliance on petrochemicals, and to maybe oversell what we can do, save the planet.” Dr Derry likened it to a quick way to find your favourite chocolate in a box at Christmas. Rather than scrabbling through, taking out one type at a time until you find your favourite, the process can immediately separate it out with minimal effort. Aquaporin has developed a membrane that can selectively transport only water molecules to quickly purify water, which is already in use across the world, and even out of this world, for space missions. Dr Bak and the team will bring their membrane expertise to the project. The team at CNRS, led by polymer scientist Dr Semsarilar, is working on a number of projects for BIOMEM, including developing a type of crystalline material called trianglamine, which they can modify through chemical processes to be hydrophobic or hydrophilic to make things like water channels or adsorption sites, which can be embedded in polymer network for purification processes. Other researchers at AIME, including Dr Derry and Professor Paul Topham, will work on the ‘glue’ to stick the biological elements of the membranes to the non-biological polymer matrix. BIOMEM will also benefit from the input of partners across Europe including dsm-firmenich, University of Copenhagen and Tampere University. The podcast was recorded just after the project kick-off meeting with all the project partners, which was held at Aston University in May 2024. Listen to the full podcast on the Aston Originals YouTube page.

Dr Alan GoddardDr Matthew DerryPaul Topham

5 min

Aston University receives £10m from Research England to establish the Aston Institute for Membrane Excellence

Image shows how tiny water channels control how water enters and exits cells through their membranes The Aston Institute for Membrane Excellence (AIME) will be set up with a £10m grant from Research England AIME will be led by Professor Roslyn Bill from Biosciences and Professor Paul Topham from Chemical Engineering and Applied Chemistry The globally unique institute will use biomimetic polymer membranes for applications such as water purification and drug development Aston University will establish the Aston Institute for Membrane Excellence (AIME), a globally unique, cross-disciplinary institute to develop novel biomimetic membranes, after receiving a major grant of £10m from Research England. AIME will be led by Professor Roslyn Bill, from the School of Biosciences, with co-lead Professor Paul Topham from the department of Chemical Engineering and Applied Chemistry (CEAC). Membranes, both biological and synthetic, are hugely important in many sectors. For example, the world’s top ten selling human medicines all target proteins in biological membranes, while synthetic polymer membranes are used in the US$100bn/year water purification industry. The team behind AIME believes that the full potential of membranes will only be realised by an interdisciplinary group spanning biology, physics and chemistry that can investigate membranes holistically. Professor Bill, a European Research Council (ERC) Advanced grantee leads Aston Membrane Proteins and Lipids (AMPL) research centre of excellence that studies the structure and function of membrane proteins and associated lipids. Professor Topham leads Aston Polymer Research Group (APRG), which investigates the nanoscale behaviour of block copolymers (a type of polymer with a structure made of more than one type of polymer molecule) and polymer technologies for membranes. AMPL and APRG have already begun collaborative research and AIME will bring together the complementary expertise of both research clusters into one institute. AIME will initially comprise the eight researchers from AMPL and APRG. Alongside the co-leads Professor Bill and Professor Topham, will be Dr Alan Goddard, Professor Andrew Devitt, Professor Corinne Spickett, Dr Alice Rothnie, Dr Matt Derry and Dr Alfred Fernandez. It plans to recruit three further academics, six tenure-track research fellows, three postdoctoral research assistants (PDRAs), six PhD students, a research technician and a business development manager. Importantly, AIME will work with many existing Aston University colleagues to build a comprehensive research community focused on all aspects of membrane science. The new AIME team will focus on the development of bioinspired, highly selective polymer structures for applications in water purification and waste remediation, nanoparticles loaded with therapeutic molecules to treat disorders ranging from chronic wounds to neurological injuries, and the purification of individual membrane proteins with polymers to study them as drug targets. The vision is for AIME to become a ‘one-stop shop’ for interdisciplinary, translational membrane research through its facilities access and expertise, ideally located in the heart of the country. Professor Bill said: “The creation of AIME is ground-breaking. Together with Aston’s investment, E3 funding will deliver a step-change in scale and the rate at which we can grow capacity. We will address intractable scientific challenges in health, disease, and biotechnology, combining our world-class expertise in polymer chemistry and membrane biology to study membranes holistically. The excellence of our science, alongside recent growth in collaborative successes means we have a unique opportunity to deliver AIME’s ambitious and inclusive vision.” Professor Topham said: “We are really excited by this fantastic opportunity to work more closely with our expert colleagues in Biosciences to create advanced technology to address real world problems. From our side, we are interested in molecular engineering, where we control the molecular structure of new materials to manipulate their properties to do the things that we want! Moreover, we are passionate about a fully sustainable future for our planet, and this investment will enable us to develop technological solutions in a sustainable or ‘green’ way.” Professor Aleks Subic, Vice-Chancellor and Chief Executive of Aston University, says: “Our new Aston Institute for Membrane Excellence (AIME) will be a regional, national, and international research leader in membrane science, driving game-changing research and innovation that will produce a pipeline of high-quality research outcomes leading to socioeconomic impact, develop future global research leaders, create advanced tech spinout companies and high value-added jobs for Birmingham and the West Midlands region. Its establishment aligns perfectly with our 2030 strategy that positions Aston University as a leading university of science, technology and enterprise.” Steven Heales, Policy Manager (Innovation) at the West Midlands Combined Authority, said: “WMCA is delighted to see Research England back the Aston Institute for Membrane Excellence. This will enable Aston University’s excellent academics and research community to work closely with businesses to make advances in membrane technology and applications. “In 2023 the West Midlands Combined Authority agreed a Deeper Devolution Trailblazer Deal with Government, which included a new strategic innovation partnership with Government. Projects like AIME are exactly the kind of impact we expect this new partnership to generate, so watch this space.” Lisa Smith, chief executive of Midlands Mindforge, the patient capital investment company formed by eight Midlands research-intensive universities including Aston University, said: “This grant is an important vote of confidence in the Midlands scientific R&D ecosystem. AIME will play an important role in the future research of pioneering breakthroughs in membrane science and enable the world-leading research team at Aston University to develop solutions to real world problems. We look forward to closely working with the Institute and nurturing best-in-field research being undertaken at Aston out of the lab and into the wider society so it can make a positive impact”. Rob Valentine, regional director of Bruntwood SciTech, the UK’s leading developer of city-wide innovation ecosystems and specialist environments and a strategic partner in Birmingham Innovation Quarter, said: "As a proud supporter of the Aston Institute for Membrane Excellence (AIME), I am thrilled at the launch of this groundbreaking initiative. AIME exemplifies Aston University's commitment to advancing cutting-edge interdisciplinary research and further raises the profile of the region’s exemplary research capabilities and sector specialisms. AIME's vision of becoming a 'one-stop shop' for translational membrane research, strategically located at the heart of the country, aligns perfectly with our strategy at Bruntwood SciTech. We are committed to working with partners, including Aston University, to develop a globally significant innovation district at the heart of the UK where the brightest minds and most inspiring spaces will foster tomorrow’s innovation.” Membrane research at Aston University has also recently received two other grants. In November 2023, Professor Bill received £196,648 from the Biotechnology and Biological Sciences Research Council’s Pioneer Awards Scheme to understand how tiny membrane water channels in brain cells keep brains healthy. In December 2023, a team led by AIME team-member Dr Derry received £165,999 from the Engineering and Physical Sciences Research Council to develop biomimetic membranes for water purification. For more information about AIME, visit the webpage.

Dr Alan GoddardRoslyn BillPaul TophamDr Matthew DerryAndrew Devitt

Media

Social

Biography

Dr Goddard joined the School of Life & Health Sciences in October 2016 as a Lecturer in Biochemistry, having spent the previous four years as a Senior Lecturer in Biochemistry at the University of Lincoln. Prior to that, he spent nearly seven years as a postdoctoral researcher at the University of Oxford. Dr. Goddard completed both his BSc and PhD at the University of Warwick.

Goddard's research interests focus around membrane proteins and the lipid membranes in which they reside. He has experience of working with a range of membrane protein systems including receptors such as GPCRs, transporters and biogenesis systems. He uses model lipid membranes to study proteins in their native environments and also to probe the effects of various compounds on the integrity of the membrane itself. For example, he has investigated the lipid-specific effects of antimicrobials and solvent on biological membranes. They have an ongoing collaboration with Green Biologics Ltd.

Areas of Expertise

Biological Membranes
Biochemistry
Lipid Membranes
Membrane Protein Systems
Antimicrobials

Education

University of Lincoln

PGCE HE

2016

University of Warwick

PhD

Biological Sciences

2006

University of Warwick

BSc (Hons)

Biological Sciences with Molecular Genetics

2002

Affiliations

  • Member of Biochemical Society (Local Ambassador and Member of Training Theme Panel)
  • Member of Microbiology Society
  • Member of British Biophysical Society
  • Senior Fellow of Higher Education Academy

Media Appearances

Alan Goddard visits

University of Lincoln - Centre for Computational Physics  online

2018-01-24

On the 24th of January 2018 Dr Alan Goddard from Aston University visited our School to discuss future collaborations and to deliver a seminar on cell membranes in biotechnology. The talk was well attended, by members of the School of Maths & Physics and the School of Life Sciences.

View More

Articles

Bioinformatic characterization of a triacylglycerol lipase produced by Aspergillus flavus isolated from the decaying seed of Cucumeropsis mannii

Journal of Biomolecular Structure and Dynamics

2022

Lipases are enzymes of industrial importance responsible for the hydrolysis of ester bonds of triglycerides. A lipolytic fungus was isolated and subsequently identified based on the ITS sequence analysis as putative Aspergillus flavus with accession number LC424503. The gene coding for extracellular triacylglycerol lipase was isolated from Aspergillus flavus species, sequenced, and characterised using bioinformatics tools. An open reading frame of 420 amino acid sequence was obtained and designated as Aspergillus flavus lipase (AFL) sequence. Alignment of the amino acid sequence with other lipases revealed the presence GHSLG sequence which is the lipase consensus sequence Gly-X1-Ser-X2-Gly indicating that it a classical lipase. A catalytic active site lid domain composed of TYITDTIIDLS amino acids sequence was also revealed. This lid protects the active site, control the catalytic activity and substrate selectivity in lipases. The 3-Dimensional structural model shared 34.08% sequence identity with a lipase from Yarrowia lipolytica covering 272 amino acid residues of the template model.

View more

Detergent-Free Membrane Protein Purification Using SMA Polymer

Methods in Molecular Biology

2022

One of the big challenges for the study of structure and function of membrane proteins is the need to extract them from the membrane. Traditionally this was achieved using detergents which disrupt the membrane and form a micelle around the protein, but this can cause issues with protein function and/or stability. In 2009 an alternative approach was reported, using styrene maleic acid (SMA) copolymer to extract small discs of lipid bilayer encapsulated by the polymer and termed SMALPs (SMA lipid particles). Since then this approach has been shown to work for a range of different proteins from many different expression systems. It allows the extraction and purification of a target protein while maintaining a lipid bilayer environment. Recently this has led to several new high-resolution structures and novel insights to function. As with any method there are some limitations and issues to be aware of. Here we describe a standard protocol for preparation of the polymer and its use for membrane protein purification, and also include details of typical challenges that may be encountered and possible ways to address those.

View more

Heterologous Expression of Membrane Proteins in E. coli

Methods in Molecular Biology

2022

Over the decades, the bacterium Escherichia coli (E. coli) has become the cornerstone of recombinant protein production, used for heterologous synthesis of a variety of membrane proteins. Due to its rapid growth to high densities in cheap media, and its ease of manipulation and handling, E. coli is an excellent host cell for a range of membrane protein targets. Furthermore, its genetic tractability allows for a variety of gene constructs to be screened for optimal expression conditions, resulting in relatively high yields of membrane protein in a short amount of time. Here, we describe the general workflow for the production of membrane proteins in E. coli. The protocols we provide show how the gene of interest is modified, transferred to an expression vector and host, and how membrane protein yields can be optimized and analyzed. The examples we illustrate are well suited for scientists who are starting their journey into the world of membrane protein production.

View more